Akamis Bio Limited is an active company incorporated on 17 November 2006 with the registered office located in Sandwich, Kent. Akamis Bio Limited was registered 19 years ago.
Akamis Bio is a clinical-stage oncology company that develops Tumor-Specific Immuno-Gene (T-SIGn®) therapeutics aimed at enabling the immune system to target and eliminate solid tumors..
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Particulars of variation of rights attached to shares
Submitted on 24 Nov 2025
Change of share class name or designation
Submitted on 24 Nov 2025
Memorandum and Articles of Association
Submitted on 21 Nov 2025
Resolutions
Submitted on 21 Nov 2025
Termination of appointment of Christopher Bowden as a director on 12 November 2025
Submitted on 19 Nov 2025
Termination of appointment of Richard Nan Shen as a director on 12 November 2025
Submitted on 19 Nov 2025
Termination of appointment of Adrian Kin Fei Chan as a director on 12 November 2025
Submitted on 19 Nov 2025
Registered office address changed from Akamis House 4-10 the Quadrant Barton Lane Abingdon Oxfordshire OX14 3YS United Kingdom to Office 20, Second Floor Innovation House, Innovation Way Discovery Park Sandwich Kent CT13 9FF on 7 October 2025
Submitted on 7 Oct 2025
Group of companies' accounts made up to 31 December 2024